Literature DB >> 14705020

Lipoxygenase interactions with natural flavonoid, quercetin, reveal a complex with protocatechuic acid in its X-ray structure at 2.1 A resolution.

Oleg Y Borbulevych1, Jerzy Jankun, Steven H Selman, Ewa Skrzypczak-Jankun.   

Abstract

PUFA metabolites have a profound effect on inflammatory diseases and cancer progression. Blocking their production by inhibiting PUFA metabolizing enzymes (dioxygenases: cyclooxygenases and LOXs) might be a successful way to control and relieve such problems, if we learn to better understand their actions at a molecular level. Compounds with strong antioxidative and free radical scavenging properties, such as polyphenols, could be effective in blocking PUFA activities, and natural flavonoids possess such qualities. Quercetin belongs to the group of natural catecholic compounds and is known as a potent, competitive inhibitor of LOX. Structural analysis reveals that quercetin entrapped within LOX undergoes degradation, and the resulting compound has been identified by X-ray analysis as protocatechuic acid (3,4-dihydroxybenzoic acid) positioned near the iron site. Its C3-OH group points toward His523, C4-OH forms a hydrogen bond with O=C from the enzyme's C-terminus, and the carboxylic group is incorporated into the hydrogen bonding network of the active-site neighborhood via Gln514. This unexpected result, together with our previous observations concerning other polyphenols, yields new evidence about the metabolism of natural flavonoids. These compounds might be vulnerable to the co-oxidase activity of LOX, leading to enzyme-stimulated oxidative degradation, which results in an inhibitor of a lower molecular weight. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14705020     DOI: 10.1002/prot.10579

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  8 in total

1.  Osteogenic differentiation of adipose-derived stem cells promoted by quercetin.

Authors:  C Zhou; Y Lin
Journal:  Cell Prolif       Date:  2014-04       Impact factor: 6.831

2.  Green Synthesis of Thiazolidine-2,4-dione Derivatives and Their Lipoxygenase Inhibition Activity With QSAR and Molecular Docking Studies.

Authors:  Melita Lončarić; Ivica Strelec; Valentina Pavić; Vesna Rastija; Maja Karnaš; Maja Molnar
Journal:  Front Chem       Date:  2022-07-05       Impact factor: 5.545

3.  A novel inhalable quercetin-alginate nanogel as a promising therapy for acute lung injury.

Authors:  Yi-Bing Chen; Ya-Bin Zhang; Yu-Le Wang; Prabhleen Kaur; Bo-Guang Yang; Yan Zhu; Lei Ye; Yuan-Lu Cui
Journal:  J Nanobiotechnology       Date:  2022-06-11       Impact factor: 9.429

4.  Cancer-relevant biochemical targets of cytotoxic Lonchocarpus flavonoids: a molecular docking analysis.

Authors:  Caitlin E Cassidy; William N Setzer
Journal:  J Mol Model       Date:  2009-07-15       Impact factor: 1.810

5.  Efficacy of Quercetin-Sensitized Cisplatin against N-Nitroso-NMethylurea Induced Testicular Carcinogenesis in Wistar Rats.

Authors:  Hend Hgm El-Diasty; Hassan El-Sayyad; Sherif Refaat; Heba A El-Ghaweet
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

6.  In Vitro Study of the Biological Potential of Wastewater Obtained after the Distillation of Four Bulgarian Oil-Bearing Roses.

Authors:  Yana Ilieva; Lyudmila Dimitrova; Almira Georgieva; Neli Vilhelmova-Ilieva; Maya Margaritova Zaharieva; Zlatina Kokanova-Nedialkova; Ana Dobreva; Paraskev Nedialkov; Vesselin Kussovski; Alexander D Kroumov; Hristo Najdenski; Milka Mileva
Journal:  Plants (Basel)       Date:  2022-04-14

7.  Inhibitory Effects of Grewia tomentosa Juss. on IgE-Mediated Allergic Reaction and DNCB-Induced Atopic Dermatitis.

Authors:  Hwa Pyoung Lee; Wooram Choi; Ki Woong Kwon; Long You; Laily Rahmawati; Van Dung Luong; Wonhee Kim; Byoung-Hee Lee; Sarah Lee; Ji Hye Kim; Jae Youl Cho
Journal:  Plants (Basel)       Date:  2022-09-27

8.  Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways.

Authors:  Ashley B Ward; Hina Mir; Neeraj Kapur; Dominique N Gales; Patrick P Carriere; Shailesh Singh
Journal:  World J Surg Oncol       Date:  2018-06-14       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.